Coverage
-
June 28, 2016
A New Jersey federal judge on Tuesday granted final approval to a $1.06 billion deal between Merck & Co. Inc. and its investors to resolve multidistrict litigation over the alleged illegal marketing of the painkiller Vioxx, saying the settlement was an "extremely fair and reasonable" conclusion to the long-running case.
11 other articles on this case.
View all »